The putative lithium-mimetic ebselen reduces impulsivity in rodent models.
Chris BarkusJacqueline-Marie M FerlandWendy K AdamsGrant C ChurchillPhilip J CowenDavid M BannermanRobert D RogersCatharine A WinstanleyTrevor SharpPublished in: Journal of psychopharmacology (Oxford, England) (2018)
These findings suggest that ebselen preferentially reduces motor impulsivity over choice impulsivity, and that inhibition of 5-HT2A receptor function is a contributing mechanism. Collectively, these data support the repurposing of ebselen as an anti-impulsive treatment and fast-tracking to clinical trials in patient groups characterised by poor impulse control.